Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.71 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.71 |
| ▸ | KARS1 | Q15046 | 4/20 | 0.65 |
| ▸ | RXRA | P19793 | 1/20 | 0.65 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.65 |
| ▸ | CDK2 | P24941 | 1/20 | 0.65 |
| ▸ | RXRB | P28702 | 1/20 | 0.65 |
| ▸ | RXRG | P48443 | 1/20 | 0.65 |
| ▸ | POLA1 | P09884 | 4/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ABHD16A | O95870 | 2/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.51 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.51 |
| ▸ | SOD1 | P00441 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2603459 | 0.94 | NR1I2 (0.71) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL14648810 | 0.92 | NR1I2 (0.68) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL16517876 | 0.90 | NR1I2 (0.66) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL14648821 | 0.88 | NR1I2 (0.64) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL2603443 | 0.88 | NR1I2 (0.75) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL2603439 | 0.87 | NR1I2 (0.74) | NR1I2OPRK1KARS1RXRACCNE1 | |
| Lambertic Acid SCHEMBL31674429 | 0.87 | NR1I2 (0.74) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL15342889 | 0.86 | NR1I2 (0.72) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL2603448 | 0.86 | NR1I2 (0.72) | NR1I2OPRK1KARS1RXRACCNE1 | |
| SCHEMBL14299763 | 0.86 | NR1I2 (0.72) | NR1I2OPRK1KARS1RXRACCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256082-A1 | Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties | VIAMET PHARMACEUTICALS, INC. (US) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256082-A1 | Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties | MMEL1, MPI, METAP1 | NR1I2 2630/4885OPRK1 4485/4885KARS1 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.